最近在不良的HIV免疫复合中取得的进展:未来将是什么样子?
1Department of Infectious Diseases, Wuhan Jinyintan Hospital, Tongji Medical College of Huazhong University of Science and Technology, Hubei Clinical Research Center for Infectious Diseases, Wuhan Research Center for Communicable Disease Diagnosis and Treatment, Chinese Academy of Medical Sciences, Joint Laboratory of Infectious Diseases and Health, Wuhan Institute of Virology and Wuhan Jinyintan Hospital, Chinese Academy of Sciences, Wuhan, Hubei, China.
Frontiers in microbiology
|August 23, 2023
概括
许多接受联合抗逆转录病毒治疗的HIV-1患者实现了免疫复原,但有些人仍然是免疫不响应者 (INR). 本综述探讨了艾滋病毒免疫恢复不完全背后的因素和机制,并讨论了治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 传染性疾病 传染性疾病
背景情况:
- 联合抗逆转录病毒疗法 (cART) 有效抑制HIV-1复制并改善CD4+T细胞计数.
- 然而,10-40%的HIV-1患者无法实现完全的免疫复原,称为免疫不响应者 (INR).
- 由于免疫恢复不完全,INRs面临更高的死亡率和非艾滋病相关的并发症.
研究的目的:
- 审查了解导致HIV-1感染免疫复原不完全的机制和因素的最新进展.
- 总结当前的治疗策略,针对免疫不响应背后的各种机制.
- 为改善免疫复原不完全的HIV-1患者的个性化治疗提供见解.
主要方法:
- 关于HIV-1免疫复合的最近研究的文献综述.
- 对影响HIV-1感染个体CD4+T细胞恢复的因素的分析.
- 对免疫不响应症患者的治疗方法的综合.
主要成果:
- 影响免疫复原的因素是复杂的,包括人口统计,同时感染,基线CD4计数,免疫激活和细胞因子失调.
- 在HIV-1中不完全免疫复合的基础机制仍然不完全理解.
- 目前对于INRs没有普遍有效的治疗方法.
结论:
- 在HIV-1感染 (INRs) 中,不完全的免疫复原是一个重大的临床挑战,有效治疗方法有限.
- 进一步研究免疫不响应的多方面的机制至关重要.
- 制定有针对性的治疗策略对于改善INRs的结果至关重要.
相关概念视频
Immunodeficiency Diseases
973
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
973
Retrovirus Life Cycles
46.2K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.2K
Pulmonary Tuberculosis I
266
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
266
Development of Immunocompetence
342
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
342


